Table 3.
Summary of excluded studies and reasons for exclusion.
| Excluded studies | Reason for exclusion |
|---|---|
| Taccone et al., Current Vascular Pharmacology 2013 | Narrative Review |
| Tauber et al., Expert Review of Anti-Infective Therapy 2016 | Narrative Review |
| Donnelly et al., Critical Care 2016 | Narrative Review |
| Goodson et al., JICM 2018 | Narrative Review |
| Danielski et al., Molecular Neurobiology 2018 | Narrative Review |
| Masse et al., Critical Care Medicine 2018 | Not about cerebral autoregulation specifically, but about cerebral perfusion in septic patients |
| Gu et al., Neurotoxicity Research 2020 | Narrative Review |
| Semenyutin et al., Frontiers in Physiology 2017 | Deal with indications to surgery in patients with compromised dynamic cerebral autoregulation |
| Vranken et al., The Journal of Extra-Corporeal Technology 2017 | Narrative Review |
| Lewis et al., Journal of Cardiothoracic and Vascular Anesthesia 2018 | Narrative Review |
| Saxena et al., Presse Medicale 2018 | Narrative Review |
| Bonow et al., Neurosurgical Focus 2019 | Narrative Review |
| Kooi et al., Expert Review of Neurotherapeutics 2018 | Narrative Review |
| Rhee et al., Pediatric Research 2018 | Narrative Review |
| Jildenstål et al., Pediatric Anaesthesia 2019 | Evaluate the agreement between frontal and occipital recordings of rScO2% |
| Montgomery et al., Anesthesia and Analgesia 2020 | The aim is to determine the performance of the co-trending method by comparing CA metrics to data derived from TCD methods. |
| Kooi et al., Clinics in Perinatology 2020 | Narrative Review |
| Govindan et al., Journal of Perinatology 2020; | Determine whether ventilator-related fluctuations in CBV |
rScO2%, regional cerebral oxygen saturation; CA, cerebral autoregulation; TDC, transcranial doppler; CBV, cerebral blood volume.